Conversely, in cancer cells harboring p53 mutations, the loss of p53 functionality results in diminished autophagy and heightened resistance to ferroptosis, thereby providing a selective advantage for tumor cells (Corazzari and Collavin, 2023). The gene discussed is TP53; the disease is neoplasm.